Walgreens Boots Alliance, Inc. and Alkermes plc: A Detailed Gross Profit Analysis

Walgreens vs. Alkermes: A Decade of Profit Growth

__timestampAlkermes plcWalgreens Boots Alliance, Inc.
Wednesday, January 1, 201417091400021569000000
Thursday, January 1, 201514494200026859000000
Friday, January 1, 201622642400029874000000
Sunday, January 1, 201733573700029162000000
Monday, January 1, 201849244800030792000000
Tuesday, January 1, 201947772900028159000000
Wednesday, January 1, 202046585200026077000000
Friday, January 1, 202156983800028067000000
Saturday, January 1, 202289368700028266000000
Sunday, January 1, 2023141036800027072000000
Monday, January 1, 2024131230100026524000000
Loading chart...

Cracking the code

A Tale of Two Companies: Walgreens Boots Alliance and Alkermes

In the ever-evolving landscape of the pharmaceutical and healthcare industry, Walgreens Boots Alliance, Inc. and Alkermes plc stand as intriguing case studies. From 2014 to 2023, Walgreens consistently showcased a robust gross profit, peaking in 2018 with a 43% increase from 2014. Despite a slight dip in 2024, Walgreens maintained a strong financial footing. In contrast, Alkermes experienced a remarkable growth trajectory, with its gross profit surging by over 700% from 2014 to 2023. This growth underscores Alkermes' strategic advancements and market adaptability. However, data for 2024 remains elusive, leaving room for speculation. As these companies navigate the complexities of the global market, their financial journeys offer valuable insights into the dynamics of profitability and growth in the healthcare sector.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025